SOPHiA GENETICS (SOPH) Operating Leases (2020 - 2025)
SOPHiA GENETICS's Operating Leases history spans 6 years, with the latest figure at $12.6 million for Q4 2025.
- On a quarterly basis, Operating Leases fell 13.81% to $12.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.6 million, a 13.81% decrease, with the full-year FY2025 number at $12.6 million, down 13.81% from a year prior.
- Operating Leases hit $12.6 million in Q4 2025 for SOPHiA GENETICS, down from $13.2 million in the prior quarter.
- Over the last five years, Operating Leases for SOPH hit a ceiling of $16.7 million in Q4 2022 and a floor of $1.9 million in Q3 2024.
- Historically, Operating Leases has averaged $12.9 million across 5 years, with a median of $14.2 million in 2024.
- Biggest five-year swings in Operating Leases: plummeted 87.3% in 2024 and later soared 593.84% in 2025.
- Tracing SOPH's Operating Leases over 5 years: stood at $13.1 million in 2021, then increased by 28.21% to $16.7 million in 2022, then fell by 6.39% to $15.7 million in 2023, then dropped by 6.83% to $14.6 million in 2024, then fell by 13.81% to $12.6 million in 2025.
- Business Quant data shows Operating Leases for SOPH at $12.6 million in Q4 2025, $13.2 million in Q3 2025, and $13.9 million in Q2 2025.